Changing face of hepatic encephalopathy: role of inflammation and oxidative stress.
The face of hepatic encephalopathy (HE) is changing. This review explores how this neurocognitive disorder, which is associated with both acute and chronic liver injury, has grown to become a dynamic syndrome that spans a spectrum of neuropsychological impairment, from normal performance to coma. The central role of ammonia in the pathogenesis of HE remains incontrovertible. However, over the past 10 years, the HE community has begun to characterise the key roles of inflammation, infection, and oxidative/nitrosative stress in modulating the pathophysiological effects of ammonia on the astrocyte. This review explores the current thoughts and evidence base in this area and discusses the potential role of existing and novel therapies that might abrogate the oxidative and nitrosative stresses inflicted on the brain in patients with, or at risk of developing, HE.
Seyan
Amit S
AS
Hughes
Robin D
RD
Shawcross
Debbie L
DL
D000641:Ammonia / Q000009:adverse effects / Q000378:metabolism; D000818:Animals; D001253:Astrocytes / Q000378:metabolism; D001921:Brain / Q000503:physiopathology; D003072:Cognition Disorders / Q000209:etiology / Q000473:pathology / Q000503:physiopathology; D006501:Hepatic Encephalopathy / Q000150:complications / Q000473:pathology / Q000503:physiopathology* / Q000628:therapy; D006801:Humans; D007113:Immunity, Innate / Q000502:physiology; D007249:Inflammation / Q000473:pathology / Q000503:physiopathology*; D018384:Oxidative Stress / Q000502:physiology*
D000641:Ammonia